Argent Biopharma Ltd (RGT) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.379x

Based on the latest financial reports, Argent Biopharma Ltd (RGT) has a cash flow conversion efficiency ratio of 0.379x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.27 Million ≈ $-2.31 Million USD) by net assets (AU$-8.63 Million ≈ $-6.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Argent Biopharma Ltd (RGT) market capitalisation for the company's overall valuation and market capitalisation.

Argent Biopharma Ltd - Cash Flow Conversion Efficiency Trend (2006–2023)

This chart illustrates how Argent Biopharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Argent Biopharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Argent Biopharma Ltd ranked by their cash flow conversion efficiency. Explore Argent Biopharma Ltd (RGT) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Tianci International, Inc. Common Stock NASDAQ:CIIT	-0.002x
Bioatla Inc NASDAQ:BCAB	0.141x
ZIMI Ltd AU:ZMM	-0.347x
UMT United Mobility Technology AG XETRA:UMD	0.141x
Jadestone Energy Inc LSE:JSE	-0.550x
SRT Marine Systems plc LSE:SRT	-0.305x
Blue Star Capital plc LSE:BLU	-0.049x
GENERIC GOLD CORP. F:1WD	N/A

Annual Cash Flow Conversion Efficiency for Argent Biopharma Ltd (2006–2023)

The table below shows the annual cash flow conversion efficiency of Argent Biopharma Ltd from 2006 to 2023. View current stock price of Argent Biopharma Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-06-30	AU$-8.03 Million ≈ $-5.68 Million	AU$-11.99 Million ≈ $-8.48 Million	1.492x	+163.57%
2022-06-30	AU$5.18 Million ≈ $3.67 Million	AU$-12.16 Million ≈ $-8.60 Million	-2.347x	-170.67%
2021-06-30	AU$13.83 Million ≈ $9.78 Million	AU$-11.99 Million ≈ $-8.48 Million	-0.867x	+73.05%
2020-06-30	AU$3.09 Million ≈ $2.19 Million	AU$-9.96 Million ≈ $-7.05 Million	-3.218x	-446.82%
2019-06-30	AU$10.80 Million ≈ $7.64 Million	AU$-6.35 Million ≈ $-4.50 Million	-0.588x	-26.86%
2018-06-30	AU$12.69 Million ≈ $8.98 Million	AU$-5.89 Million ≈ $-4.17 Million	-0.464x	-57.30%
2017-06-30	AU$15.79 Million ≈ $11.17 Million	AU$-4.66 Million ≈ $-3.29 Million	-0.295x	-7.40%
2016-06-30	AU$11.73 Million ≈ $8.30 Million	AU$-3.22 Million ≈ $-2.28 Million	-0.275x	+14.35%
2015-06-30	AU$1.93 Million ≈ $1.36 Million	AU$-617.71K ≈ $-437.07K	-0.321x	-208.50%
2014-06-30	AU$4.55 Million ≈ $3.22 Million	AU$-472.74K ≈ $-334.49K	-0.104x	-54.01%
2013-06-30	AU$7.94 Million ≈ $5.62 Million	AU$-536.08K ≈ $-379.31K	-0.067x	+86.00%
2012-06-30	AU$787.42K ≈ $557.15K	AU$-379.45K ≈ $-268.48K	-0.482x	-17.80%
2011-06-30	AU$828.30K ≈ $586.08K	AU$-338.82K ≈ $-239.74K	-0.409x	-223.14%
2010-06-30	AU$-3.14 Million ≈ $-2.22 Million	AU$-1.04 Million ≈ $-737.66K	0.332x	-99.30%
2009-06-30	AU$-8.79K ≈ $-6.22K	AU$-416.04K ≈ $-294.38K	47.331x	+20017.04%
2008-06-30	AU$1.94 Million ≈ $1.37 Million	AU$-460.26K ≈ $-325.67K	-0.238x	+44.28%
2007-06-30	AU$3.81 Million ≈ $2.70 Million	AU$-1.63 Million ≈ $-1.15 Million	-0.426x	-2973.25%
2006-06-30	AU$2.76 Million ≈ $1.95 Million	AU$41.00K ≈ $29.01K	0.015x	--

About Argent Biopharma Ltd

AU:RGT Australia Drug Manufacturers - Specialty & Generic

Market Cap

$2.44 Million

AU$3.44 Million AUD

Market Cap Rank

#29857 Global

#1725 in Australia

Share Price

AU$0.03

Change (1 day)

+0.00%

52-Week Range

AU$0.03 - AU$0.11

All Time High

AU$125.00